Emerging Therapeutic Targets in Merlin-Deficient Tumors

被引：0
|
作者：
Hanemann, Clemens O.
Ammoun, Sylwia
Zhou, Lu
机构：
来源：
ANNALS OF NEUROLOGY | 2012年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S18 / S18
页数：1
相关论文
共 50 条
  • [1] Emerging therapeutic targets in schwannomas and other merlin-deficient tumors
    Sylwia Ammoun
    C. Oliver Hanemann
    Nature Reviews Neurology, 2011, 7 : 392 - 399
  • [2] Emerging therapeutic targets in schwannomas and other merlin-deficient tumors
    Ammoun, Sylwia
    Hanemann, C. Oliver
    NATURE REVIEWS NEUROLOGY, 2011, 7 (07) : 392 - 399
  • [3] IGF/IGFBP SIGNALING IN MERLIN-DEFICIENT TUMORS
    Hanemann, C. O.
    Ammoun, S.
    Schmid, M. C.
    Ristic, N.
    Ercolano, E.
    Zhou, L.
    NEURO-ONCOLOGY, 2010, 12 : 22 - 22
  • [4] The scaffold protein KSR1, a novel therapeutic target for the treatment of Merlin-deficient tumors
    L Zhou
    J Lyons-Rimmer
    S Ammoun
    J Müller
    E Lasonder
    V Sharma
    E Ercolano
    D Hilton
    I Taiwo
    M Barczyk
    C O Hanemann
    Oncogene, 2016, 35 : 3443 - 3453
  • [5] The scaffold protein KSR1, a novel therapeutic target for the treatment of Merlin-deficient tumors
    Zhou, L.
    Lyons-Rimmer, J.
    Ammoun, S.
    Mueller, J.
    Lasonder, E.
    Sharma, V.
    Ercolano, E.
    Hilton, D.
    Taiwo, I.
    Barczyk, M.
    Hanemann, C. O.
    ONCOGENE, 2016, 35 (26) : 3443 - 3453
  • [6] THE POTENTIAL OF CRL4DCAF1 AND KSR1 AS THERAPEUTIC TARGETS IN MERLIN-DEFICIENT MENINGIOMA
    Rimmer, Jade Lyons
    Baiz, Daniele
    Ercolano, Emanuela
    Hanemann, Oliver
    NEURO-ONCOLOGY, 2018, 20 : 10 - 10
  • [7] A hypothesis about the potential role of statin administration as adjuvant treatment in the management of Merlin-deficient tumors
    Brotis, Alexandros G.
    Tsitsopoulos, Parmenion P.
    Paraskevi, Tsiamalou M.
    Tasiou, Anastasia
    Di Rocco, Concienzio
    Fountas, Kostas N.
    INTERDISCIPLINARY NEUROSURGERY-ADVANCED TECHNIQUES AND CASE MANAGEMENT, 2014, 1 (01): : 11 - 15
  • [8] IDENTIFICATION AND TARGETING PATHWAYS INVOLVED IN THE DEVELOPMENT OF MERLIN-DEFICIENT TUMOURS
    Ammoun, S.
    Provenzano, L.
    Zhou, L.
    Schmid, M. C.
    Hanemann, C. O.
    ANTICANCER RESEARCH, 2014, 34 (10) : 5805 - 5805
  • [9] Cellular prion protein (PrPC) in the development of Merlin-deficient tumours
    L Provenzano
    Y Ryan
    D A Hilton
    J Lyons-Rimmer
    F Dave
    E A Maze
    C L Adams
    R Rigby-Jones
    S Ammoun
    C O Hanemann
    Oncogene, 2017, 36 : 6132 - 6142
  • [10] Cellular prion protein (PrPC) in the development of Merlin-deficient tumours
    Provenzano, L.
    Ryan, Y.
    Hilton, D. A.
    Lyons-Rimmer, J.
    Dave, F.
    Maze, E. A.
    Adams, C. L.
    Rigby-Jones, R.
    Ammoun, S.
    Hanemann, C. O.
    ONCOGENE, 2017, 36 (44) : 6132 - 6142
12345